1.4.3.1: D-aspartate oxidase
This is an abbreviated version!
For detailed information about D-aspartate oxidase, go to the full flat file.
Word Map on EC 1.4.3.1
-
1.4.3.1
-
d-amino
-
n-methyl-d-aspartate
-
nmda
-
d-serine
-
d-glutamate
-
octopus
-
nmdar-dependent
-
d-alanine
-
prepulse
-
humicola
-
d-amino-acid
-
d-ser
-
d-glu
-
drug development
-
molecular biology
-
medicine
- 1.4.3.1
-
d-amino
- n-methyl-d-aspartate
- nmda
- d-serine
- d-glutamate
- octopus
-
nmdar-dependent
- d-alanine
-
prepulse
- humicola
-
d-amino-acid
- d-ser
- d-glu
- drug development
- molecular biology
- medicine
Reaction
Synonyms
aspartic oxidase, C47A10.5 gene product, C47Ap, ChDASPO, ChDDO, D-Asp oxidase, D-aspartic oxidase, D-AspO, DAO, DASOX, DASPO, DDO, DDO-1, DDO-2, DDO-3, DDO1, DDO3, F18E3.7a gene product, F18Ep
ECTree
Advanced search results
Application
Application on EC 1.4.3.1 - D-aspartate oxidase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
medicine
the additional N-terminal peptide present in the DASPO_369 splicing isoform only has been identified in hippocampus of Alzheimer's disease female patients, while peptides corresponding to the remaining part of the protein are present in samples from male and female healthy controls and Alzheimer's disease patients. Upon expression in U87 human glioblastoma cells, the DASPO_369 protein shows a lower expression compared with the canonical isoform. Both protein isoforms are active, localize to the peroxisomes, are very stable, and are primarily degraded through the ubiquitin-proteasome system
molecular biology
-
This enzyme is proposed to have a role in the inactivation of the synaptically released D-aspartate. Its C-terminus has a peroxisome targeting signal.
-
a DDO inhibitor that augments brain D-Asp levels can be a potent antipsychotic drug for the treatment of NMDA receptor-related disease
drug development
-
a DDO inhibitor that augments brain D-Asp levels can be a potent antipsychotic drug for the treatment of NMDA receptor-related disease